> Japan's Takeda has bought into Santhera's experimental treatment for Friedreich's Ataxia. Story
> Isotechnika is touting interim results for their Phase III trial of its lead immunosuppressive drug. Release
> India's Orchid Chemicals plans to raise $100 million to pay down debt and fund new development. Story
> Regulators have cited Merck for violating FDA rules when it changed a manufacturing process for a leukemia drug without testing to see if it was effective. Story
> Cobra Biomanufacturing and Auxilium Pharmaceuticals have extended their agreement for the production and supply of the protein biopharmaceutical AA4500. Release
> Cytochroma has announced positive results for a Phase Ib trial of its experimental psoriasis treatment. Release
And Finally... New "smart" bio-nanotubes may help improve drug delivery techniques. Release